摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-3-羟基-2-环己烯-1-酮 | 89466-67-1

中文名称
2-氯-3-羟基-2-环己烯-1-酮
中文别名
2-氯-3-羟基-2-环己烯酮
英文名称
2-chloro-3-hydroxycyclohex-2-enone
英文别名
2-Chloro-1,3-cyclohexanedione;2-Chlor-cyclohexandion-(1,3);2-Chloro-3-hydroxycyclohex-2-en-1-one
2-氯-3-羟基-2-环己烯-1-酮化学式
CAS
89466-67-1
化学式
C6H7ClO2
mdl
MFCD00174264
分子量
146.573
InChiKey
ZJPMFCHLKVIZRG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:f8c440a376ad8aca5a8abba4c0305fbe
查看
Name: 2-Chloro-3-hydroxycyclohex-2-en-1-one 97% Material Safety Data Sheet
Synonym:
CAS: 89466-67-1
Section 1 - Chemical Product MSDS Name:2-Chloro-3-hydroxycyclohex-2-en-1-one 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
89466-67-1 2-Chloro-3-hydroxycyclohex-2-en-1-one 97% unlisted
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 89466-67-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 203 - 206 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H7ClO2
Molecular Weight: 147

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, acid chlorides.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 89466-67-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Chloro-3-hydroxycyclohex-2-en-1-one - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 89466-67-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 89466-67-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 89466-67-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为产物:
    描述:
    2-diazocyclohexane-1,3-dione 在 dirhodium tetraacetate 氯丁烷 作用下, 反应 10.0h, 以96%的产率得到2-氯-3-羟基-2-环己烯-1-酮
    参考文献:
    名称:
    一种由重氮二羰基化合物方便有效地制备β-取代的α-卤代烯酮的方法
    摘要:
    已经研究了铑(II)催化的环状重氮二羰基化合物与各种卤化物的反应。用酰基卤可以高收率生产β-酰氧基α-卤代烯酮。使用苄基卤化物,可以良好的产率获得β-苄氧基α-卤代烯酮。与亚甲基卤的反应以良好的产率产生β-卤代甲氧基α-卤代烯酮,而与乙基卤和乙二卤的反应以高产率产生β-羟基α-卤代烯。这些反应提供了有用且快速的进入β-取代的α-卤代烯酮的途径。还已经用卤化pathway描述了形成这些产物的机理途径。
    DOI:
    10.1016/j.tet.2003.09.087
点击查看最新优质反应信息

文献信息

  • Condensed ring compound
    申请人:Yasuma Tsuneo
    公开号:US20060258722A1
    公开(公告)日:2006-11-16
    The present invention aims at providing a novel fused ring compound having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes, more particularly, a compound represented by the formula: wherein Ar is an optionally substituted cyclic group, ring A is a ring optionally further substituted (provided that the ring is not thiazole, oxazole, imidazole and pyrazole), Xa and Xb are each independently a bond or a spacer having a main chain of 1 to 5 atom(s), Xc is O, S, SO or SO 2 , ring B is a 5- to 7-membered ring, Xd is a bond, CH or CH 2 , is a single bond when Xd is a bond or CH 2 , or a double bond when Xd is CH, and R 1 is an optionally substituted hydroxy group, and a salt thereof.
    本发明旨在提供一种新的融合环化合物,具有GPR40受体功能调节作用,并可用作胰岛素分泌剂或用于预防或治疗糖尿病的药物,更具体地说,是一种由以下公式表示的化合物:其中Ar是一个可选取代的环状基团,环A是一个环状基团,可选地进一步取代(前提是该环不是噻唑、噁唑、咪唑和吡唑),Xa和Xb分别是1到5个原子的主链具有键或间隔物,Xc是O、S、SO或SO2,环B是一个5-至7-成员环,Xd是键、CH或CH2,当Xd是键或CH2时为单键,当Xd为CH时为双键,R1为可选取代的羟基,以及其盐。
  • CONDENSED RING COMPOUND
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1630152A1
    公开(公告)日:2006-03-01
    The present invention aims at providing a novel fused ring compound having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes, more particularly, a compound represented by the formula: wherein Ar is an optionally substituted cyclic group, ring A is a ring optionally further substituted (provided that the ring is not thiazole, oxazole, imidazole and pyrazole), Xa and Xb are each independently a bond or a spacer having a main chain of 1 to 5 atom(s), Xc is O, S, SO or SO2, is ring B is a 5- to 7-membered ring, Xd is a bond, CH or CH2, •••••• is a single bond when Xd is a bond or CH2, or a double bond when Xd is CH, and R1 is an optionally substituted hydroxy group, and a salt thereof.
    本发明旨在提供一种新型融合环化合物,该化合物具有调节 GPR40 受体功能的作用,可用作预防或治疗糖尿病的胰岛素分泌剂或药物制剂,特别是由式表示的化合物: 其中 Ar 是任选取代的环状基团,环 A 是任选进一步取代的环(条件是该环不是噻唑、噁唑、咪唑和吡唑),Xa 和 Xb 各自独立地是键或主链为 1 至 5 个原子的间隔物,Xc 是 O、S、SO 或 SO2、 是 环 B 是 5 至 7 元环、 Xd 是键、CH 或 CH2、 ------ 是单键(当 Xd 是键或 CH2 时)或双键(当 Xd 是 CH 时),以及 R1 是任选取代的羟基及其盐。
  • Reactions of a Cyclic Rhodium Carbenoid with Aromatic Compounds and Vinyl Ethers
    作者:Michael C. Pirrung、Jiancun Zhang、Karen Lackey、Daniel D. Sternbach、Frank Brown
    DOI:10.1021/jo00112a036
    日期:1995.4
    Further investigation has been made of the reactions between the cyclic diazo compound 2-diazo-1,3-cyclohexanedione and aromatic heterocycles or vinyl ethers, catalyzed by rhodium carboxylates. The extraordinary reactivity of the carbenoid derived from this diazo compound is shown by its ready reaction with solvents such as dichloromethane, dichloroethane, and fluorobenzene. Detailed investigation of its reactions with furans have shown that steric interactions dominate, both in terms of regioselectivity with unsymmetrical substrates and yield. This reaction provides a useful entry to the furo[2,3-b]furan ring system found in a number of naturally-occurring compounds and is formally a 1,3-dipolar cycloaddition. Products of net C-H insertion and with reverse regiochemistry (furo[3,2-b]furan ring system) were also detected. With pyrroles and thiophenes, cycloadducts were seen in a few cases, but were generally the exception; C-H insertion products dominate these reactions. Vinyl ethers proved reliable reactants in providing dipolar cycloadducts. The results of this study have been interpreted in terms of four pathways: an initial cyclopropanation would produce a spirocyclic dicarbonyl system that on heterolytic cleavage of one of the two cyclopropane bonds would give a zwitterion. The partitioning of such a zwitterion between ring closure and proton transfer would define the ratio of C-H insertion and dipolar cycloaddition products. Both thermodynamic and stereoelectronic arguments have been advanced to explain the observations and were supported by calculations.
  • De Buyck, L.; Seynaeve, D.; De Kimpe, N., Bulletin des Societes Chimiques Belges, 1985, vol. 94, # 5, p. 363 - 370
    作者:De Buyck, L.、Seynaeve, D.、De Kimpe, N.、Verhe, R.、Schamp, N.
    DOI:——
    日期:——
  • US7820837B2
    申请人:——
    公开号:US7820837B2
    公开(公告)日:2010-10-26
查看更多